MiR-101-3p and Syn-Cal14.1a Synergy in Suppressing EZH2-Induced Progression of Breast Cancer.

Onco Targets Ther · 2020 · PMC7532305 · PMID 33061442

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

It was highly significant that the use of a mixture of both miR-101-3p mimic in combination with syn-cal14.1a proved to be the most effective treatment, resulting in a dramatic increased expression of cleaved PARP ( Figure 7C and D ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.